2001 Conditions Epilepsy Patients 
CannaTech
SEPTEMBER 16, 2018
Canada has been at the forefront of shaping much of the rhetoric surrounding cannabis since 2001. Doctors have remained integral parts of a patient’s cannabis journey through what is known as the Access to Cannabis for Medical Purposes Regulation (ACMPR) act. The Need for Cannabis Education Tailored to Patient and Doctor.
The Cannigma
DECEMBER 13, 2021
In 2001, in one of the most progressive social moves surrounding drug usage, Portugal decriminalized all drugs, weed included. Patients with cannabis licenses can obtain medical marijuana in Portugal from licensed pharmacies and dispensaries. Medical: Legal Recreational: Decriminalized. Portugal cannabis laws: medical usage.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
MAY 19, 2021
Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes. Shutterstock).
Leaf Science
JULY 23, 2019
In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex. Cannabis & general health. It wouldn’t have got the level of 1.3
Cannabis Law Report
AUGUST 16, 2019
Enrollment has increased from 15,000 to nearly 50,000 patients since Murphy took office. New York’s medical marijuana program has approximately 102,000 patients. Pennsylvania now includes anxiety and Tourette’s on the list of qualifying conditions for enrollment in its medical marijuana program. Patrick McKnight.
Cannabis Law Report
OCTOBER 20, 2019
It is also the first FDA approved drug for the treatment of patients with Dravet syndrome. Big Pharma companies want botanical marijuana to remain illegal because it is financially beneficial to them, not because synthetic marijuana is decidedly better for patients.” as a Schedule II substance. marijuana companies. xxiii] [link].
Cannabis Law Report
JULY 30, 2021
Balkan Insight is reporting… eople with long-term illnesses are still being given prison sentences in Serbia for using cannabis to treat medical conditions, as the government has been stalling on legal reform while vowing even harsher anti-drug enforcement. Patients are in a terrible situation.
Expert insights. Personalized for you.
66 
Let's personalize your content